Lorsept-INTENSIVE spray spray for the oral mucosa (1.5mg / 5.0mg) / 1ml 30ml in pack No. 1

Name:
Lorcept-intensive. Release formSpray for local use. Dosage 30 ml Quantity per pack: 1 pc. ProducerRubicon is white. INN benzidamine + cetylpyridinium chloride. FTGS Means for the treatment of diseases of the oral cavity and pharynx. Antiseptics. ATC code: R02AA20
Description:
Transparent, colorless or yellowish liquid. Composition 1 ml contains: active ingredients: benzydamine hydrochloride – 1.50 mg, cetylpyridinium chloride (in the form of cetylpyridinium chloride monohydrate) – 5.00 (5.26) mg; A single press corresponds to 0.1 ml of spray and contains 0.15 mg of benzydamine hydrochloride and 0.5 mg of cetylpyridinium chloride (as monohydrate). excipients: glycerin, ethanol (in the form of a 96% solution), macrogolglycerol hydroxystearate, sodium saccharin, peppermint oil, purified water. The medicinal product contains ethyl alcohol: 26 mg/single dose. Pharmacological properties Pharmacodynamics: Benzydamine hydrochloride is a non-steroidal anti-inflammatory drug with anti-inflammatory and local analgesic effects. The mechanism of action is associated with inhibition of prostaglandin synthesis. Cetylpyridinium chloride is an antiseptic from the group of quaternary ammonium compounds that act as a cationic detergent. It is active against Gram-positive and, to a lesser extent, Gram-negative bacteria. Cetylpyridinium chloride also has antifungal properties. Pharmacokinetics: Of the two active ingredients that make up the drug, only benzydamine is absorbed through the mucous membranes. Therefore, a pharmacokinetic interaction between cetylpyridinium and benzydamine at the systemic level is not expected. The absorption of benzydamine was shown by detecting the active substance in the blood serum, the amount of which, however, was not enough to provide a systemic effect. At the same time, the absorption of benzydamine when using dosage forms that dissolve in the oral cavity is higher than those for topical use. When used in recommended doses, the absorption of benzydamine when using a spray for the oral mucosa is negligible. Excretion occurs mainly by the kidneys, to a greater extent in the form of inactive metabolites. Indications for use Local treatment as part of the complex therapy of infectious and inflammatory diseases of the oral cavity and pharynx (tonsillitis, pharyngitis, stomatitis, gingivitis). Method of application and dosage The drug is contraindicated in children under 6 years of age. Children aged 6 to 12 years: to receive a single dose, press the dispenser once, irrigate the inflamed area. If necessary, the procedure is repeated every 2 hours 3-5 times a day. In children aged 6 to 12 years, the drug should be used under adult supervision. Children aged 12 years and older: to receive a single dose, press the dispenser once or twice, irrigate the inflamed area. If necessary, the procedure is repeated every 2 hours 3-5 times a day. Adults: to receive a single dose, press the dispenser once or twice, irrigate the inflamed area. If necessary, the procedure is repeated every 2 hours 3 to 5 times a day. To achieve the optimal effect, He should be used immediately before or immediately after brushing your teeth. Recommended doses should not be exceeded. Duration of admission – up to 7 days. Elderly patients Recommendations for use correspond to those for adults. How to use Before the first use of the spray, press the dispenser several times until a jet appears. If the drug has not been used for a long time (at least one week), then press the dispenser once until a jet appears. Inhalation of the drug should be avoided. Open your mouth wide, aim the spray nozzle at the throat, hold your breath and press the dispenser 1-2 times. Side effects Classification of the incidence of side effects according to the World Health Organization: very often (> 1/10), often (> 1/100 to < 1/10), infrequently (> 1/1000 to < 1/100), rarely (> 1 /10000 to < 1/1000), very rare (< 1/10000), frequency not known (cannot be estimated from available data). Rare Very rare Frequency not known Side effects Hypersensitivity immune system reactions Side effects Burning sensation or numbness of the nervous system of the oral mucosa Side effects Bronchospasm of the respiratory system, chest organs and mediastinum Side effects Irritation of the mucosa Gastrointestinal oral cavity, feeling burning tract in the oral cavity Disorders from the side Urticaria of the skin and subcutaneous tissue Photosensitivity Contraindications Hypersensitivity to the active substances or other components of the drug. This dosage form is not intended for use in children under 6 years of age. Overdose Symptoms of an overdose of benzydamine: agitation, convulsions, increased sweating, ataxia, tremor, vomiting. Signs and symptoms of intoxication as a result of ingestion of significant amounts of cetylpyridinium chloride: nausea, vomiting, respiratory disorders, cyanosis, asphyxia due to paralysis of the respiratory muscles, depression of the central nervous system, arterial hypotension, coma. The lethal dose for humans is about 1 - 3 g (corresponding to 2000 - 6000 single doses of a spray). There is no specific antidote. Treatment is symptomatic. Precautions The drug should not be used for more than 7 days. If there are no noticeable signs of improvement after 3 days of treatment, you should consult your doctor. Dosage forms for topical use can cause hypersensitivity reactions, especially with long-term therapy. In this case, it is recommended to stop treatment and consult a doctor to prescribe appropriate therapy. The drug should not be used simultaneously with anionic compounds (for example, present in toothpaste). Accordingly, it is not recommended to use the drug immediately before or after brushing your teeth. Avoid getting the drug in the eyes. It is necessary to avoid inhalation or ingestion of the drug during its use. Cetylpyridinium chloride should not be used in mucosal lesions due to possible problems with wound healing. In children aged 6 to 12 years, the drug should be used under adult supervision. The drug contains a small amount of ethyl alcohol: 26 mg/single dose. Children The drug is contraindicated in children under 6 years of age. Application during pregnancy and lactation Pregnancy Data on the use of benzydamine hydrochloride and cetylpyridinium chloride in pregnant women are limited. The use of the drug during pregnancy is not recommended. Breastfeeding There are no data on the presence of benzydamine hydrochloride or its metabolites in breast milk. A risk to newborns and infants cannot be excluded. When prescribing a drug to a woman who is breastfeeding, a decision should be made to stop breastfeeding, taking into account its benefits for the child and the expected benefit of therapy for the mother. The ability to influence the reaction rate when driving The drug has no or little effect on the ability to drive vehicles or work with mechanisms. Interaction with other drugs Simultaneous use with drugs from the group of antiseptics should be avoided. Storage conditions and shelf life Storage conditions: At a temperature not exceeding 25 °C. Shelf life: 2 years. Do not use after the expiration date. After opening the vial, the drug should be used within 1 month. Packing: 30 ml in a polyethylene bottle sealed with a spray nozzle with a protective cap with instructions for use in a cardboard pack. Holiday rules Without a prescription. Buy Lorcept-INTENSIVE spray spray for the oral mucosa (1.5mg/5.0mg)/1ml 30ml in pack №1 pack No. 1 Instructions for use for Lorcept-INTENSIVE spray spray for the oral mucosa (1.5 mg / 5.0 mg) / 1ml 30 ml in pack No. 1